NCT00660153 2012-08-28Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal CancersAVEO Pharmaceuticals, Inc.Phase 1 Completed30 enrolled